臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51271337 線上人數 : 625 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"po lan"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 16-25 / 40 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國立成功大學	2022-06	Respiratory etiological surveillance among quarantined patients with suspected lower respiratory tract infection at a medical center in southern Taiwan during COVID-19 pandemic	Huang;Chien-Ping;Tsai;Chin-Shiang;Su;Po-Lan;Huang;Tang-Hsiu;Ko;Wen-Chien;Lee;Nan-Yao
國立成功大學	2022-04	Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients-A retrospective cohort study	Kuo;Chin-Wei;Wang;Sheng-Yuan;Tsai;Huey-Pin;Su;Po-Lan;Cia;Cong-Tat;Lai;Ching-Han;Chen;Chang-Wen;Shieh;Chi-Chang;Lin;Sheng-Hsiang
國立成功大學	2022-03-18	Durable Response of Dabrafenib, Trametinib, and Capmatinib in an NSCLC Patient With Co-Existing BRAF-KIAA1549 Fusion and MET Amplification: A Case Report	Chou;Yun-Tse;Lin;Chien-Chung;Lee;Chung-Ta;Pavlick;Dean, C.;Su;Po-Lan
國立成功大學	2022-02-28	The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy	Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-02	Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report	Lin;Chung-Fu;Liu;Szu-Yu;Lo;Tzu-Kun;Lee;Julia, Yu-Yun;Su;Po-Lan
國立成功大學	2022-01	The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic	Tsai;Chin-Shiang;Huang;Tang-Hsiu;Su;Po-Lan;Chen;Chiung-Zuei;Chen;Chang-Wen;Ko;Wen-Chien;Lee;Nan-Yao
國立成功大學	2022-01	Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors	Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-01	Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019	Wu;Chi-Jung;Cia;Cong-Tat;Wang;Hsuan-Chen;Chen;Chang-Wen;Lin;Wei-Chieh;Lee;Jen-Chieh;Chen;Po-Sheng;Hsieh;Chih-Cheng;Li;Wei-Ting;Su;Po-Lan;Liao;Xin-Min;Hsieh;Ming-;I;Choi;Pui-Ching;Ko;Wen-Chien
國立成功大學	2021-12	Electrical Impedance Tomography Analysis Between Two Similar Respiratory System Compliance During Decremetal PEEP Titration in ARDS Patients	Su;Po-Lan;Lin;Wei-Chieh;Ko;Yen-Fen;Cheng;Kuo-Sung;Chen;Chang-Wen
國立成功大學	2021-11	Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report	Wu;Chi-Hao;Su;Po-Lan;Hsu;Che-Wei;Chu;Chang-Yao;Lin;Chien-Chung

顯示項目 16-25 / 40 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目